North Star Investment Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

North Star Investment Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-200	Closed	-$4.07K	–	1242
2023 Q3	$4.07K	Hold	200	–	–	﹤0.01%	980
2023 Q2	$4.67K	Hold	200	–	–	﹤0.01%	983
2023 Q1	$4.65K	Hold	200	–	–	﹤0.01%	997
2022 Q4	$5.03K	Sell	200 -100	-33%	-$2.69K	﹤0.01%	970
2022 Q3	$8K	Hold	300	–	–	﹤0.01%	841
2022 Q2	$9K	Hold	300	–	–	﹤0.01%	848
2022 Q1	$10K	Hold	300	–	–	﹤0.01%	871
2021 Q4	$13K	Hold	300	–	–	﹤0.01%	849
2021 Q3	$15K	Hold	300	–	–	﹤0.01%	791
2021 Q2	$16K	Hold	300	–	–	﹤0.01%	770
2021 Q1	$14K	Hold	300	–	–	﹤0.01%	738
2020 Q4	$14K	Buy	300 +200	+200%	+$8.63K	﹤0.01%	729
2020 Q3	$4K	Buy	+100	New	+$3.85K	﹤0.01%	876

Other funds holding IDNA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

North Star Investment Management's IDNA Position: Q4 2023 in Review

North Star Investment Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2023, closing a stake of 200 shares — an estimated $4.07K sold.

North Star Investment Management first reported a position in IDNA in Q3 2020 and held it in 13 quarters. The position peaked at $16K in Q2 2021. 66 funds tracked by Wall St. Rank hold IDNA as of Q4 2023.

North Star Investment Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2023 after selling out during the quarter.
North Star Investment Management sold 200 iShares Genomics Immunology and Healthcare ETF shares in Q4 2023, an estimated $4.07K.
North Star Investment Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 13 quarters.
North Star Investment Management's iShares Genomics Immunology and Healthcare ETF position peaked at $16K in Q2 2021.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2023.

Based on North Star Investment Management's 13F filing for Q4 2023, filed 10 Jan 2024.